Please use this identifier to cite or link to this item:
Title: Therapy for Gastroenteropancreatic Neuroendocrine Tumors: drug evaluation reports review in Spain
Author: Darbà, Josep
Ascanio, Meritxell
Keywords: Endocrinologia
Issue Date: 2019
Publisher: Maghira & Maas
Abstract: In Spain it is necessary to conduct additional studies to determine place in therapy and cost-effectiveness of a drug. The main objective of this study is to identify all drug assessments and health technology assessment reports of the drugs for gastroenteropancreatic (GEP) neuroendocrine tumors (NET) at a national, regional and hospital level and to summarize the efficacy in terms of outcome measures, adverse events, economic impact and final recommendations.
Note: Reproducció del document publicat a:
It is part of: Neuroendocrinology Letters, 2019, vol. 39, num. 8, p. 537-543
ISSN: 0172-780X
Appears in Collections:Articles publicats en revistes (Economia)

Files in This Item:
File Description SizeFormat 
691114.pdf798.35 kBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons